Multiple Ascending Dose Study of ALZ-801

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
Phase I, single-center, double-blind, randomized, placebo-controlled, parallel-group study of the safety, tolerability, and pharmacokinetics (PK) in plasma and urine, of multiple ascending doses of ALZ-801 (capsule, Part 1; prototype tablet Part 2) and the primary metabolite in healthy male or female subjects.
Epistemonikos ID: 22a064cb0f06a491e50f5a1e5e1755a81087e131
First added on: May 06, 2024